投稿者 | Akhrimenko, Vladimir; Garcia, Montserrat; Aguirre, Carmelo; Agirre, Urko; Morera-Herreras, Teresa; Hernandez-Palacios, Rafael; Medrano, Juan; Lertxundi, Unax |
組織名 | NanoBioCel Group, Laboratory of Pharmaceutics, Faculty of Pharmacy, University of;the Basque Country UPV/EHU, Paseo de la Universidad 7, Vitoria-Gasteiz 01006,;Spain.;Biobizkaia Health Research Institute, Osakidetza Basque Health Service,;Galdakao-Usansolo Hospital, Basque Country Pharmacovigilance Unit, Galdakao,;Biobizkaia Health Research Institute, Department of Pharmacology, Faculty of;Medicine and Nursing, University of the Basque Country (UPV/EHU), Leioa, Spain.;Research Unit, Osakidetza Basque Health Service, Barrualde-Galdakao Integrated;Health Organisation, Galdakao-Usansolo Hospital, Galdakao, Spain. Kronikgune;Institute for Health Services Research, Barakaldo, Spain; Network for Research on;Chronicity, Primary Care, and Health Promotion (RICAPPS), Galdakao, Spain.;Department of Pharmacology, Faculty of Medicine and Nursing, University of the;Basque Country (UPV/EHU), 48940, Leioa, Spain; Neurodegenerative diseases Group,;Biobizkaia Health Research Institute, Barakaldo, Bizkaia, Spain.;Internal Medicine Service. Araba Psychiatric Hospital. Araba Mental Health;Network, C/alava 43, 01006 Vitoria-Gasteiz. Alava, Spain.;Psychiatry Service. Araba Psychiatric Hospital. Araba Mental Health Network,;C/alava 43, 01006 Vitoria-Gasteiz. Alava. Spain.;Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba;Mental Health Network, Araba Psychiatric Hospital, Pharmacy Service,;Vitoria-Gasteiz, Spain. c/Alava 43, 01006 Vitoria-Gasteiz, Alava, Spain.;Electronic address: unax.lertxundietxebarria@osakidetza.net. |